Vietnam Investment Review on MSN

Antengene presents first ATG 207 preclinical data on immune tolerance at EULAR 2026

SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering ...
Memeburn

16 Best AI Tools for Business in 2026: Tested & Ranked

Discover the best AI tools for business in 2026. We tested 16 leading platforms for automation, analytics, productivity, and ...

Innovative Bifunctional Fusion Protein ATG-207 Shows Promise For Autoimmune Disease Treatment

Conclusion: ATG-207 represents a differentiated immune tolerance–restoring strategy that integrates precision T cell ...

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...